Healthcare Sector

GILD

Market Tracker

  • GILD (Selected)

    Gilead Sciences, Inc.

GILD Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

GILD Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

GILD Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

GILD Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
09/19/2025 CALL $116.00 2,663 +1,369 +105.80%
09/12/2025 CALL $117.00 1,088 +1,003 +1,180.00%
09/05/2025 CALL $113.00 1,178 +925 +365.61%
10/17/2025 PUT $100.00 1,253 +501 +66.62%
09/05/2025 PUT $115.00 383 +234 +157.05%
10/17/2025 PUT $105.00 1,304 +157 +13.69%
10/10/2025 PUT $110.00 899 -34 -3.64%
10/10/2025 PUT $105.00 853 -35 -3.94%
09/05/2025 PUT $118.00 8 -49 -85.96%
09/05/2025 CALL $114.00 505 -73 -12.63%
09/19/2025 PUT $110.00 2,161 -74 -3.31%
09/19/2025 CALL $115.00 4,076 -77 -1.85%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

GILD Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 38.12M 2.91B
Income Fund of America Inc 2.70% 33.74M 2.58B
Vanguard 500 Index Fund 2.32% 28.99M 2.21B
Dodge & Cox Stock Fund 2.02% 25.19M 1.92B
Washington Mutual Investors Fund 1.57% 19.64M 1.5B
American Balanced Fund 1.37% 17.14M 1.31B
American Mutual Fund Inc 1.33% 16.67M 1.27B
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.31% 16.4M 1.25B
Fidelity 500 Index Fund 1.10% 13.75M 1.05B
SPDR S&P 500 ETF Trust 1.08% 13.5M 1.03B

GILD News

  • Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer

    09/04 11:00 am

    GlobeNewswire Inc.

    Read more
  • Pharming Group appoints Kenneth Lynard as Chief Financial Officer

    09/02 01:00 am

    GlobeNewswire Inc.

    Read more
  • Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy

    08/21 11:45 am

    Benzinga

    Read more
  • Ligand to Participate in September Investor Conferences

    08/19 04:00 pm

    GlobeNewswire Inc.

    Read more
  • MacroGenics Revenue Doubles in Q2

    08/14 04:21 pm

    The Motley Fool

    Read more
  • Kymera Revenue Drops 55 Percent in Q2

    08/11 07:28 am

    The Motley Fool

    Read more
  • Tango (TNGX) Q2 Revenue Drops 52%

    08/05 08:25 pm

    The Motley Fool

    Read more
  • IDEAYA (IDYA) Q2 Net Loss Improves 27%

    08/05 04:23 pm

    The Motley Fool

    Read more
  • MCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Report 2025: Over 12 ML1 Inhibitor Drugs In Clinical Trials

    08/05 04:28 am

    GlobeNewswire Inc.

    Read more
  • Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales

    07/25 12:12 pm

    Benzinga

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

    07/06 10:00 am

    GlobeNewswire Inc.

    Read more
  • Why Gilead Scinces Stock Tumbled on Tuesday

    06/10 05:22 pm

    The Motley Fool

    Read more
  • 2 Stocks, 100%+ Combined Gains - All From Spotting Mispricing Before the Crowd

    06/08 03:45 am

    Investing.com

    Read more
  • Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

    06/06 07:00 am

    GlobeNewswire Inc.

    Read more
  • Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

    06/05 06:38 pm

    GlobeNewswire Inc.

    Read more
  • Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités

    05/09 10:46 am

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

    04/28 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer

    04/21 02:49 pm

    Benzinga

    Read more
  • 2 High-Yielding ETFs Retirees Can Safely Build Their Portfolios Around

    04/17 05:45 am

    The Motley Fool

    Read more
  • 2 Top Dividend Stocks That Could Set You Up for Life

    04/09 07:00 am

    The Motley Fool

    Read more
  • Is Vertex Pharmaceuticals Stock a Buy?

    04/08 09:45 am

    The Motley Fool

    Read more
  • Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

    04/08 04:48 am

    GlobeNewswire Inc.

    Read more
  • 3 Stocks Leading Healthcare’s Comeback as Wall Street Turns Defensive

    04/02 12:14 pm

    Investing.com

    Read more
  • Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

    03/21 12:31 pm

    Benzinga

    Read more
  • Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide

    03/12 08:48 am

    GlobeNewswire Inc.

    Read more
  • The Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)

    03/11 04:20 am

    The Motley Fool

    Read more
  • Non-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight

    02/26 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Questex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education

    02/24 11:00 am

    GlobeNewswire Inc.

    Read more
  • Why Gilead Sciences Stock Is Jumping Today

    02/12 01:21 pm

    The Motley Fool

    Read more
  • Gilead Sciences Beats Q4 EPS Forecast

    02/11 05:40 pm

    The Motley Fool

    Read more
  • 3 Fabulous Dividend Stocks to Buy in February

    02/09 03:30 pm

    The Motley Fool

    Read more
  • These 2 Dividend Stocks Are Absolute Bargains Right Now

    02/08 09:30 am

    The Motley Fool

    Read more
  • 3 Top AI-Powered Biotech Stocks to Buy in February

    02/06 10:45 am

    The Motley Fool

    Read more
  • Global Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica

    01/17 04:30 am

    GlobeNewswire Inc.

    Read more
  • Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

    01/09 03:12 pm

    Benzinga

    Read more
  • NUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries

    01/09 11:53 am

    GlobeNewswire Inc.

    Read more
  • Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus

    01/08 03:07 pm

    Benzinga

    Read more
  • Galapagos wil aandeelhouderswaarde ontgrendelen met voornemen tot splitsing in twee beursgenoteerde entiteiten

    01/08 02:30 am

    GlobeNewswire Inc.

    Read more
  • Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

    01/08 02:30 am

    GlobeNewswire Inc.

    Read more
  • Burkitt Lymphoma Global Clinical Trials Review 2024: Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status

    12/23 01:44 pm

    GlobeNewswire Inc.

    Read more
  • Cancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology

    12/09 08:10 am

    Benzinga

    Read more
  • Coccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report

    12/04 08:00 am

    GlobeNewswire Inc.

    Read more
  • Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology

    11/26 08:30 pm

    Benzinga

    Read more
  • Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology

    11/26 08:30 pm

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024

    11/17 11:30 am

    GlobeNewswire Inc.

    Read more
  • Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease

    11/15 03:14 pm

    Benzinga

    Read more
  • 3 Spectacular High-Yield Dividend Stocks to Buy in November

    11/10 10:30 am

    The Motley Fool

    Read more
  • Merus annonce ses résultats financiers pour le troisième trimestre 2024 et fait le point sur ses activités

    11/02 06:18 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: